Titan Pharmaceuticals Inc (TTNP.OQ)
TTNP.OQ on NASDAQ Stock Exchange Capital Market
0.88USD
13 Jul 2018
0.88USD
13 Jul 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$0.88
$0.88
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
16,560
16,560
52-wk High
$2.80
$2.80
52-wk Low
$0.60
$0.60
Select another date:
Mon, Apr 2 2018
BRIEF-Titan Pharmaceuticals Q4 Loss Per Share $0.17
* TITAN PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
BRIEF-Titan Pharmaceuticals Executes Agreement For Acquisition By Molteni Of Probuphine In Europe And Other Territories
* TITAN EXECUTES AGREEMENT FOR ACQUISITION BY MOLTENI OF PROBUPHINE® IN EUROPE AND OTHER SELECT TERRITORIES
BRIEF-Titan Announces Amendment To Horizon Loan Agreement
* TITAN PHARMACEUTICALS INC - ENTRY INTO AN AMENDMENT TO JULY 2017 LOAN AGREEMENT WITH HORIZON TECHNOLOGY FINANCE CORPORATION
Select another date:
- Titan Pharmaceuticals' (TTNP) CEO Sunil Bhonsle on Q1 2018 Results - Earnings Call Transcript
- Titan Pharmaceuticals' (TTNP) CEO Sunil Bhonsle on Q4 2017 Results - Earnings Call Transcript
- Your Daily Pharma Scoop: Omeros' Omidria, Titan Signs Agreement, Reata Announces Top-Line Results
- Wall Street Breakfast: Markets Weighed Down By Cohn Exit
- Wall Street Breakfast: Infrastructure Details Coming Today
- Titan Pharmaceuticals' (TTNP) CEO Sunil Bhonsle on Q3 2017 Results - Earnings Call Transcript